Your browser doesn't support javascript.
loading
Abnormal protein SUMOylation in liver disease: novel target for therapy.
Yang, Yanfang; Yu, Fuxun.
Afiliación
  • Yang Y; Department of Central Laboratory, Guizhou Provincial People's Hospital, Guiyang, 550002, China. yangyanfang@gzu.edu.cn.
  • Yu F; NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People's Hospital, Guiyang, 550002, China. yangyanfang@gzu.edu.cn.
J Mol Med (Berl) ; 102(6): 719-731, 2024 06.
Article en En | MEDLINE | ID: mdl-38565749
ABSTRACT
SUMOylation is an important protein post-translational modification (PTM) process, in which the small ubiquitin-like modifier (SUMO) protein covalently binds to the target protein and regulates stability, subcellular localization, and protein-protein interaction of the target protein. Protein SUMOylation exerts crucial regulatory function in the liver, and its abnormalities are associated with various liver-related disease processes. This review focuses on the biological functions of protein SUMOylation in liver-related diseases in recent years, summarizes the molecular mechanisms of SUMOylation in the replication of hepatitis viruses and the occurrence of hepatocellular carcinoma, and discusses the significance of SUMOylation in liver-related disorders, which is essential for understanding liver biological processes and formulating therapeutic strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sumoilación / Hepatopatías Límite: Animals / Humans Idioma: En Revista: J Mol Med (Berl) Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sumoilación / Hepatopatías Límite: Animals / Humans Idioma: En Revista: J Mol Med (Berl) Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: China